Annual Report

Overview

The report highlights the company's broad patient-health impact, including millions of patients treated across antifungal, antiviral, antibiotic, cardiometabolic, diabetes, GI, liver, oncology, orthopedic, urology and nephrology areas. It reports three female directors on the seven-member board and describes the WILL-CORP initiative to support women's leadership. The Group also reports two operational one-megawatt solar plants at Raiwind and Nowshera. Consolidated net revenue reached 18,856,899,587 Rupees for 2025.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2025
Period: Ends 30 June 2025
Language: English
Pages
File size
Restatement: Disclosed

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services